Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.
Phase II randomized trial comparing high-dose IFN-alpha2b with temozolomide plus cisplatin as systemic adjuvant therapy for resected mucosal melanoma.
复制标题
II 期随机试验，比较高剂量 IFN-α2b 与替莫唑胺加顺铂作为切除粘膜黑色素瘤的全身辅助治疗。
作者：
Siming Li;Yan Kong;Bixia Tang;Jun Guo
